A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia.
about
A distinct "side population" of cells with high drug efflux capacity in human tumor cellsLung cancer-initiating cells: a novel target for cancer therapyEmerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approachBrain tumor stem cells: Molecular characteristics and their impact on therapyEmerging Non-Canonical Functions and Regulation by p53: p53 and StemnessCancer stem cells in basic science and in translational oncology: can we translate into clinical application?SALL4, a stem cell factor, affects the side population by regulation of the ATP-binding cassette drug transport genesSmall molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancerAdvances in complex multiparameter flow cytometry technology: Applications in stem cell research.Evidence for a qualitative hierarchy within the Hoechst-33342 'side population' (SP) of murine bone marrow cells.Prospective isolation of murine hematopoietic stem cells by expression of an Abcg2/GFP allele.Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsivenessSquamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade.Persistence of side population cells with high drug efflux capacity in pancreatic cancer.Flow cytometry of the side population (SP).Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineageIdentification and characterization of side population cells in embryonic stem cell cultures.Uterine leiomyomas exhibit fewer stem/progenitor cell characteristics when compared with corresponding normal myometriumOvarian cancer stem-like side-population cells are tumourigenic and chemoresistant.The therapeutic promise of the cancer stem cell concept.Fluorouracil selectively enriches stem-like leukemic cells in a leukemic cell line.The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype.Oncolytic reovirus effectively targets breast cancer stem cells.Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine.Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy.Genotypic and phenotypic characterization of side population of gastric cancer cell lines.Identification and targeting of cancer stem cells.Perspective beyond cancer genomics: bioenergetics of cancer stem cellsKruppel-like factor 5 is not required for K-RasG12D lung tumorigenesis, but represses ABCG2 expression and is associated with better disease-specific survival.Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer.Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeuticsEWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.Recombinant human endostatin could eliminate the pro-angiogenesis priority of SP cells sorted from non-small cell lung cancer cells.The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell lineWill cancer stem cells provide new therapeutic targets?Clinical significance of side population in ovarian cancer cells.Targeting cancer-initiating cells with oncolytic viruses.Isolation and applications of prostate side population cells based on dye cycle violet efflux
P2860
Q24564100-B6EB61F7-185E-4414-A46C-4666A0E88873Q26824222-B469121D-85B4-41CB-AABF-EF23150E5CF0Q26849477-3616CE34-5B86-41F9-BE79-5823A03CE9B0Q27003138-DDD508AA-B976-4A04-832D-3093A45883BCQ28077156-C18FC11C-2E2F-4444-A79A-2129E361B061Q28081844-34BF0BC0-3AA9-4294-88DF-9B1E67670801Q28477812-714AF944-9CA5-4A87-84E0-540B72BEE987Q28481728-96EF05AA-2CD5-4ACE-9438-7FF2A8B32B4DQ30479710-4D4EB5C7-6FD2-4C57-A993-8086B3B62828Q33212598-B43976C9-840B-4410-AAEE-DE2445230F59Q33234180-6FB351C8-FB50-436E-A1EB-5FDDADFF7B1BQ33250633-8D4588A3-429F-4491-B467-252EC585B23DQ33316454-8AB22450-5492-48D9-BD76-52CBAA5A83D5Q33317784-1C5329F9-C0CF-4546-A542-6D9756305512Q33366775-A6081B93-70AE-4647-9E4B-4D25EDE8C3E7Q33366973-FAB37CE5-77E9-403B-8F78-9AA1238597AEQ33396339-1B589677-634A-40E6-A548-2316EF526476Q33508776-EB7A9DBB-FC94-42FA-AF61-9D32807B2FA9Q33547790-D3788287-1077-47AC-A053-7B29E89964EDQ33559711-14C3FD0F-42E2-44C0-9FC4-C9E9BD6B9CD8Q33660279-5DB37782-A4AC-4696-B873-DA93B4430AE0Q33674720-C1CE88A5-E5C9-4A8A-AC96-0F27614B3039Q33713657-EE4A04B2-8423-4C51-906A-02216D7EB27BQ33718767-689AD3DE-59EE-4335-890D-D46E97AEBCFFQ33829820-1EA47BA3-A0D4-42DF-9957-9CF3EA0534F5Q33855045-A8786183-3AB7-4063-9ED0-AFE639DA618EQ33921460-A6616BE8-B2A6-4889-9953-07B63D2D7214Q34015182-CF45E101-C423-4E70-93CA-D95E74507A59Q34087027-A4CE3F3F-24E5-4398-92EF-2747C70E1207Q34137275-995A527A-261F-4E0D-B3B4-DBCDC775372AQ34204333-27AD3BBB-1F7C-453C-837C-A724F2CA8C63Q34279411-32E3397A-7308-495E-89CD-85E3425C7BA9Q34283431-31444CE9-C604-4671-8C50-9B0CBA9B72E6Q34362205-7B0E84E1-9843-41A0-A209-C38F05E6BC8CQ34374056-EA7003A8-70BE-4D22-A7F9-599C2FC68558Q34544440-E3B34482-72ED-4F79-935D-BBA921261DDBQ34551538-7583EC4B-9CF5-41FD-A6E3-B5CBB4B6EC73Q34634654-A8B2554B-D3FE-4673-87B1-A5E0EDB9CBD1Q34659011-1E775414-1803-4479-8E04-FE1A3B644761Q34680017-F8BFC37F-47B4-45DB-A7BB-EF2069C51975
P2860
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia.
@ast
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia.
@en
type
label
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia.
@ast
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia.
@en
prefLabel
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia.
@ast
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia.
@en
P2093
P356
P1433
P1476
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia.
@en
P2093
M A Goodell
M Andreeff
M K Brenner
P304
P356
10.1182/BLOOD.V98.4.1166
P407
P577
2001-08-01T00:00:00Z